Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.

[1]  J. Endicott,et al.  Quality of Life Enjoyment and Satisfaction Questionnaire , 2016 .

[2]  E. Holmes,et al.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology , 2009, Journal of psychopharmacology.

[3]  J. Calabrese,et al.  Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. , 2016, The Journal of clinical psychiatry.

[4]  M. Bourin,et al.  Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study , 2014, International Journal of Bipolar Disorders.

[5]  A. Ravindran,et al.  Lithium for bipolar disorder: a review of the recent literature , 2014, Expert review of neurotherapeutics.

[6]  J. Calabrese,et al.  Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. , 2014, Journal of affective disorders.

[7]  J. Calabrese,et al.  Medication adherence in a comparative effectiveness trial for bipolar disorder , 2014, Acta psychiatrica Scandinavica.

[8]  Seong-Jin Cho,et al.  Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression. , 2014, Journal of affective disorders.

[9]  T. Ketter,et al.  Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. , 2014, Journal of affective disorders.

[10]  J. Calabrese,et al.  Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder , 2014, Clinical trials.

[11]  A. Young,et al.  A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder , 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[12]  J. Calabrese,et al.  Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. , 2014, Journal of affective disorders.

[13]  T. Suppes,et al.  MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO‐CONTROLLED TRIALS , 2013, Depression and anxiety.

[14]  J. Calabrese,et al.  The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. , 2013, The American journal of psychiatry.

[15]  J. Calabrese,et al.  Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies , 2013, International Journal of Bipolar Disorders.

[16]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[17]  P. Falkai,et al.  The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline. , 2013, Deutsches Arzteblatt international.

[18]  W. Nolen,et al.  The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double‐blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144) , 2013, Bipolar disorders.

[19]  G. Keating,et al.  Quetiapine: a review of its use in the management of bipolar depression. , 2012, CNS drugs.

[20]  C. Eap,et al.  Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population. , 2012, Journal of psychiatric research.

[21]  G. Alexander,et al.  Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. , 2012, Psychiatric services.

[22]  W. Nolen,et al.  Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). , 2011, The Journal of clinical psychiatry.

[23]  W. Coryell,et al.  Factors Associated with the Prescribing of Olanzapine, Quetiapine, and Risperidone in Patients with Bipolar and Related Affective Disorders , 2011, Pharmacotherapy.

[24]  T. Barnes.  Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.

[25]  J. Calabrese,et al.  A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. , 2010, Alcoholism, clinical and experimental research.

[26]  R. Lam,et al.  Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). , 2010, Journal of affective disorders.

[27]  J. Calabrese,et al.  Bipolar Depression: Overview and Commentary , 2010, Harvard review of psychiatry.

[28]  R. Baldessarini,et al.  Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004 , 2010, Human psychopharmacology.

[29]  T. Suppes,et al.  Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. , 2010, Journal of affective disorders.

[30]  G. Goodwin,et al.  Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial , 2010, The Lancet.

[31]  A. Young,et al.  A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). , 2010, The Journal of clinical psychiatry.

[32]  A. Young,et al.  A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). , 2010, The Journal of clinical psychiatry.

[33]  T. Treuer,et al.  Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[34]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[35]  P. Grof,et al.  A critical appraisal of lithium's efficacy and effectiveness: the last 60 years. , 2009, Bipolar disorders.

[36]  Arun Ravindran,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. , 2013, Bipolar disorders.

[37]  T. Suppes,et al.  Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). , 2009, The American journal of psychiatry.

[38]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[39]  J. Calabrese,et al.  International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression. , 2008, The Journal of clinical psychiatry.

[40]  J. Calabrese,et al.  Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study. , 2008, Journal of affective disorders.

[41]  T. Suppes,et al.  Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). , 2008, Journal of affective disorders.

[42]  G. Wang,et al.  Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study , 2008, Current medical research and opinion.

[43]  J. Caro,et al.  Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder , 2007, Expert review of pharmacoeconomics & outcomes research.

[44]  H. Möller,et al.  A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania , 2007, International clinical psychopharmacology.

[45]  M. Frye,et al.  Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network , 2007, International clinical psychopharmacology.

[46]  S. Selek,et al.  Atypical antipsychotics related metabolic syndrome in bipolar patients. , 2007, Journal of affective disorders.

[47]  R. Hirschfeld.  Guideline Watch (November 2005): Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2nd Edition , 2007 .

[48]  J. Calabrese,et al.  Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression: A Double-blind, Placebo-controlled Study (The BOLDER II Study) , 2006, Journal of clinical psychopharmacology.

[49]  T. Ketter,et al.  Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice , 2006, Current medical research and opinion.

[50]  J. Ballenger.  A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder , 2006 .

[51]  R. McIntyre,et al.  Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial , 2005, European Neuropsychopharmacology.

[52]  M. Nishino,et al.  [TSH (thyroid stimulating hormone)]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[53]  B. Carpiniello,et al.  Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder , 2005, Clinical practice and epidemiology in mental health : CP & EMH.

[54]  Joseph R Calabrese,et al.  The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. , 2005, The Journal of clinical psychiatry.

[55]  J. Calabrese,et al.  A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. , 2005, The American journal of psychiatry.

[56]  H. Grunze,et al.  A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. , 2005, The Journal of clinical psychiatry.

[57]  G. Keating,et al.  Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. , 2005, Drugs.

[58]  J. Mullen,et al.  Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania , 2004, Journal of clinical psychopharmacology.

[59]  G. Sachs,et al.  Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. , 2004, Bipolar disorders.

[60]  T. Denson,et al.  Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[61]  S. Potkin,et al.  Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. , 2002, Clinical therapeutics.